Dr. Nina S. Sung, MD

Dr. Sung practices at Sacramento Medical Center in Sacramento, California, part of Kaiser Permanente.

Dr. Sung's NPI, 1104137199, was assigned on June 24, 2010. Dr. Sung graduated from Feinberg School of Medicine in 2010. Dr. Sung holds California license 126150.

Dr. Sung's primary practice is Sacramento Medical Center, at 2025 Morse Avenue, Sacramento, CA 95825 in Sacramento County. The practice phone is (916) 973-5000.

Dr. Sung's primary practice is Sacramento Medical Center in Sacramento, California, part of Kaiser Permanente. Dr. Sung is also affiliated with The Mount Sinai Hospital. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Sung to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sung practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sung's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Sung is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sung's licenses on file in 6 states: California, Montana, Ohio, Colorado, New York and Illinois.

CMS data shows 103 Medicare services from Dr. Sung across 2 procedure codes in 2024, for 62 Medicare patients. Medicare paid $16,682 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Sung in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 56% have high cholesterol. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sung's median patient age at 63, with 39% women.

In 2024, Dr. Sung wrote 129 Medicare Part D claims for 27 patients. 27% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $21,316 in total drug cost. In 2023, CMS named 156 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Sung for performance year 2024, reported as part of a group. Dr. Sung accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Sung from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $19.

Dr. Sung graduated from Feinberg School of Medicine in 2010.

Dr. Sung is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.